%20(1).webp)

The diagnosis has been given, the patient is absorbing it, and there is a screening schedule that has not been started. What happens next is unplanned in many UK services. It is also the one contact point you reliably control, which makes it the right place to screen for co-occurring conditions, not merely the convenient one.
This guide sets out a screening and recording protocol for the point of adult ADHD diagnosis: which domains to cover, which instruments to use, and what to write down so the next clinician can act on it. Differential diagnosis, the cardiac work-up and complex presentations are covered in their own guides, linked below. For assessing ADHD where other conditions cloud the picture, see our guide to DIVA-5 in complex presentations.
Co-occurring conditions are common. The UKAAN adult ADHD assessment quality assurance standard (2024) notes that over 60% of adults with ADHD present with one or more comorbid disorders. The updated European consensus statement (Kooij and colleagues, 2019) puts the lifetime comorbidity rate at 60 to 80%.
The same UKAAN standard treats screening as essential, not optional. It says it is essential to screen for common mental health problems, both current and previous, and to ask about disorders such as binge eating, anorexia or bipolar disorder that may change the management of ADHD. It also says risk assessments should always be completed.
There is a practical reason too. A dated, scored baseline makes a shared care request easier for a GP practice to accept, and it gives anyone who reviews the patient later something to compare against.
Every screen should produce a number or a documented negative, dated at the point of diagnosis.
A workable minimum, completed at the feedback appointment rather than posted out afterwards:
Questionnaires posted out after the appointment often come back late, incomplete or not at all. If the appointment is the only reliable point of collection, collect there.
Score the depression measure, interpret it, and record a management decision at the appointment, rather than leaving the interpretation to the GP. Low mood that predates the ADHD presentation and dominates current impairment may be the first treatment target.
Ask separately about elevated mood. Bipolar disorder is one of the conditions UKAAN names as able to change ADHD management, and the Elvanse Adult SmPC advises particular care when using stimulants in patients with comorbid bipolar disorder. Patients rarely volunteer a good fortnight from years ago unless asked directly. For the differential itself, see our guide to distinguishing ADHD from bipolar disorder. Where mood instability is chronic and relational, our ADHD and EUPD differential guide covers the overlap.
Apply the same rule: score, interpret, record. Then note the direction of travel. Anxiety that has built up after years of missed deadlines and criticism behaves differently from anxiety present since early childhood, and the distinction can change what you treat first. That is a formulation question, not a scoring one, so write down your reasoning as well as the number.
Current use affects medication choice, and UKAAN specifically names substance misuse and the potential for misuse or diversion of prescribed medicines as risks to consider. Ask about cannabis used for sleep in particular. Patients often do not think of it as drug use, so it is rarely volunteered.
Record the AUDIT-C score and the drug enquiry, including negatives. For background on the overlap, see our articles on ADHD and substance use and alcohol use in ADHD.
Do not accept “bad sleep” as an answer. Record usual sleep onset, duration, snoring or witnessed pauses in breathing, and restless legs. Each needs different handling, and any of them is likely to be blamed on the medication later if no baseline was recorded. Our guide to sleep problems in ADHD covers the wider picture.
The eating screen is often skipped, yet it has one of the most direct prescribing consequences. The Elvanse Adult SmPC lists decreased appetite as a very common side effect and weight loss as common in adults. Starting a stimulant without knowing about restrictive eating is a recognised risk, not bad luck. Record the screen even when it is negative. See also ADHD and disordered eating.
Ask about self-harm and suicidal thoughts directly, and record both the answer and your risk judgement. Where risk is active, good practice is to pause the post-diagnostic pathway and follow the risk pathway, and the record should say so.
If medication is likely, the cardiovascular history and observations belong in the same record. Write blood pressure and pulse as values, not as “normal”, and record height and weight. NICE NG87 sets out which features need a cardiology opinion before prescribing and when an ECG is needed. We cover both in detail in our guide to cardiovascular checks before ADHD medication, so they are not repeated here.
Also record the condition that would reopen any deferred medication decision, and put the monitoring plan in the shared care request as actual intervals. A practice asked to monitor “as per guidance” is being asked to do your planning. Our guide to the ADHD annual review and physical health monitoring sets out what follows. Numbers travel between services. Impressions do not.
Yes. It can identify conditions that outweigh the ADHD in current impact, and it gives the next clinician a dated baseline whether or not medication is ever started.
The GP can repeat it, but the diagnosing clinician sees the patient at the point of diagnosis. A recorded baseline from that appointment also supports any later shared care request.
Book a separate feedback appointment and tell the patient at the outset. A screen rushed into the last few minutes is unlikely to be scored or interpreted properly.
Screening at the point of diagnosis is not an administrative extra. It is what makes the treatment that follows safe, and what lets the next clinician pick up where you left off. Score it, date it, interpret it and record the negatives.
Global ADHD Network’s ADHD assessor training covers screening, formulation and report writing in depth.
